Dr. Rojas-Quintero is researching how Metformin, a long-used diabetes drug, may be able to slow fibrosis in the lungs.

Veterans with COPD and current tobacco use faced a reduced likelihood for tobacco dependence treatment if they lived in a ...

OSA and COPD present with symptoms that often go undetected for too long. How can clinicians recognize symptoms faster?

Cytisinicline significantly increases quit rates in smokers with or without COPD while being safe and well tolerated.

The disappointing result means that AZ will be unable to follow in the footsteps of GSK, whose IL-5 inhibitor Nucala ...

The biologic dosed every 2 weeks reduced moderate or severe COPD exacerbations over 52 weeks by a relative 15.4% compared ...

Treatment improved patient reported outcomes, reduced viral load, and maintained lung function compared to placebo; Multi-center, international trial ...

AstraZeneca said on Wednesday its asthma drug Fasenra failed to control the rate of flare-ups in patients with chronic ...

In COPD, patient initiation and persistent use of guideline-concordant maintenance inhaled medications is subpar.

A phase 3 trial evaluating benralizumab for the treatment of COPD did not meet its primary endpoint, according to AstraZeneca.

On 03 September 2025, Hoffmann-La Roche conducted a study is to assess the long-term safety and to explore the efficacy of ...

Among patients with COPD, at least 50% reported that the disease impacts their daily life and emotional health, according to ...